National Bank of Canada’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-500
| Closed | -$3.32K | – | 2577 |
|
|
2024
Q2 | $3.32K | Hold |
500
| – | – | ﹤0.01% | 2196 |
|
|
2024
Q1 | $2.66K | Hold |
500
| – | – | ﹤0.01% | 2218 |
|
|
2023
Q4 | $3.03K | Sell |
500
-214
| -30% | -$1.3K | ﹤0.01% | 2227 |
|
|
2023
Q3 | $4.79K | Buy |
714
+214
| +43% | +$1.44K | ﹤0.01% | 2132 |
|
|
2023
Q2 | $3.51K | Hold |
500
| – | – | ﹤0.01% | 2235 |
|
|
2023
Q1 | $4.17K | Hold |
500
| – | – | ﹤0.01% | 2188 |
|
|
2022
Q4 | $5.73K | Hold |
500
| – | – | ﹤0.01% | 2129 |
|
|
2022
Q3 | $6K | Hold |
500
| – | – | ﹤0.01% | 2123 |
|
|
2022
Q2 | $5K | Hold |
500
| – | – | ﹤0.01% | 2204 |
|
|
2022
Q1 | $8K | Hold |
500
| – | – | ﹤0.01% | 2198 |
|
|
2021
Q4 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 2217 |
|